Evolving Inflammatory Bowel Disease Treatment Paradigms: Top-Down Versus Step-Up
Authors:
- Remo PanaccioneRPRemo Panaccione
- 1 January 2010
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 94 (1) , 1-18
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- Meta‐analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitisAlimentary Pharmacology & Therapeutics, 2009
- 751e Adalimumab Induces and Maintains Mucosal Healing in Patients with Moderate to Severe Ileocolonic Crohn's Disease – First Results of the Extend TrialGastroenterology, 2009
- Investigation of Crohn's Disease Risk Loci in Ulcerative Colitis Further Defines Their Molecular RelationshipGastroenterology, 2009
- Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's diseaseNature Genetics, 2008
- Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based CohortGastroenterology, 2007
- New serological markers in inflammatory bowel disease are associated with complicated disease behaviourGut, 2007
- Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trialGut, 2007
- The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5‐year UK inception cohortAlimentary Pharmacology & Therapeutics, 2006
- Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's diseaseGastrointestinal Endoscopy, 2006
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987